200
Participants
Start Date
November 30, 2025
Primary Completion Date
March 31, 2027
Study Completion Date
May 31, 2027
Macupatide
Administered SC
Eloralintide
Administered SC
Macupatide Placebo
Administered SC
Eloralintide Placebo
Administered SC
Momentum Darlinghurst, Darlinghurst, Sydney
Emeritus Research, Botany
The AIM Centre / Hunter Diabetes Centre, Merewether
Go Centro Medico San Nicolás, San Nicolás
Momentum Sunshine, Melbourne
Emeritus Research, Camberwell
Core Research Group, Brisbane
Cornerstone Dermatology, Coorparoo
CDH Research Institute Pty Ltd, Maroochydore
Instituto de Investigaciones Clínicas Córdoba, Córdoba
Clinical Research Partners, LLC, Richmond
Eastern Virginia Medical School (EVMS) Medical Group, Norfolk
Pivotal Research Solutions, Stonecrest
Teak Research Consults, Lawrenceville
Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
AGILE Clinical Research Trials, LLC, Sandy Springs
SKY Clinical Research Network Group-Brown, Atlanta
Mercy Family Clinic, Dallas
Velocity Clinical Research, Dallas, Dallas
PlanIt Research, PLLC, Houston
Aavon Clinical Trials, Richmond
Consano Clinical Research, LLC, Shavano Park
Texas Valley Clinical Research, Weslaco
Kalo Clinical Research, West Valley City
Central Phoenix Medical Clinic, Phoenix
Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC, Gilbert
Pima Heart, Tucson
Vector Clinical Trials, Las Vegas
Northwest Clinical Research Center, Bellevue
Rainier Clinical Research Center, Renton
Universal Research Group, Tacoma
Premier Research, Trenton
Centro de Investigaciones Metabólicas (CINME), Buenos Aires
CENUDIAB, Buenos Aires
CEDIC, CABA
Clínica Universitaria Reina Fabiola, Córdoba
San Juan Bautista School of Medicine - Clinical Research Unit, Caguas
Mgcendo Llc, San Juan
Eli Lilly and Company
INDUSTRY